Improved insulin sensitivity and reduced adiposity with aP2 driven TLR4 overexpression in transgenic mice

被引:0
|
作者
Ono-Moore, Kikumi D. [1 ,3 ]
Zhao, Ling [4 ]
Huang, Shurong [3 ]
Kim, Jeong-a [5 ]
Rutkowsky, Jennifer M. [2 ]
Snodgrass, Ryan G. [1 ,3 ]
Schneider, Dina A. [3 ]
Quon, Michael J. [6 ]
Hwang, Daniel H. [1 ,3 ]
机构
[1] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA
[2] Univ Calif Davis, Dept Cardiovasc Med, Davis, CA 95616 USA
[3] USDA ARS, Western Human Nutr Res Ctr, Davis, CA USA
[4] Univ Tennessee, Dept Nutr, Knoxville, TN 37996 USA
[5] Univ Alabama Birmingham, Dept Cell Biol, Div Endocrinol Diabet & Metab, Birmingham, AL 35294 USA
[6] Univ Maryland, Dept Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA
来源
FASEB JOURNAL | 2013年 / 27卷
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
1083.6
引用
收藏
页数:1
相关论文
共 21 条
  • [21] Pre-treatment with a novel synthetic TLR4 agonist prior to challenge with mouse-adapted H1N1. and H2N3 influenza strains reduced morbidity and mortality in BALB/c mice
    Whitacre, Margaret
    Ward, Janine
    Jackson, Konner
    Bess, Laura
    Jayah, Rachel
    Sands, Cherrokee
    Arayangkul, Hathaipat
    Khalaf, Juhienah K.
    Miller, Shannon M.
    Evans, Jay T.
    Bazin, Helene G.
    JOURNAL OF IMMUNOLOGY, 2022, 208 (01):